Details for 2017829176

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE VON ANTI-CD20/ANTI-CD3-BISPEZIFISCHEN ANTIKÖRPERN UND 4-1BB (CD137)-AGONISTEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017829176

EP Publication Number

3559034

E-Number

1340839

Language

PCT Number

EP17083222

Publication Date

30.10.2019 A

02.12.2020 B1

Registration Date

02.12.2020

AT Publication Date

15.12.2020

Application Date

18.12.2017

Registration Number

Priorities

20.12.2016

16205493

IPC

C07K 16/28 20060101AFI20200703BHEP

Maximum Duration of Protection

18.12.2037

Owner

F. Hoffmann-La Roche AGGrenzacherstrasse 124 4070 BaselCH

Representative

No representatives present

Inventor

BACAC, Marinac/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

FERRARA KOLLER, Claudiac/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

KLEIN, Christianc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

PERRO, Marioc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

SAM, Johannesc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

UMAÑA, Pabloc/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

XU, Weic/o Roche Glycart AG Wagistrasse 10 8952 SchlierenCH

Information about Fees